Assumptions and false comparisons

Chin, Jane Y.
December 2005
Pharmaceutical Representative;Dec2005, Vol. 35 Issue 12, p34
The article cites ways on how sales representatives can avoid giving false clinical data to physicians. Representatives must not make assumptions about drugs. They must discuss clinical data within the confines of that specific study. The definitive comparison between the efficacy and safety of two drugs must be used.


Related Articles

  • Working with pharmaceutical companies. Jones, Nick // Pulse;2/15/2012, Vol. 72 Issue 6, p25 

    The article offers the author's insights regarding the tips on how general practitioners (GPs) may build a research trial and enhance relationship with the pharmaceutical industry. The author states that the patients must enter the research voluntarily, and they can withdraw without giving...

  • Briefs.  // GP: General Practitioner;5/12/2003, p10 

    Presents news briefs related to medical care in Great Britain as of May 12, 2003. Publishing of information on pharmaceutical company clinical trials involving Great Britain patients on a web site launched by the Association of the British Pharmaceutical Industry; The National Asthma Campaign...

  • Let's give a little for our common purpose. Pollard, Tom // British Journal of Community Nursing;Aug2002, Vol. 7 Issue 8, p392 

    Editorial. Comments on the participation of general practitioners (GP) during the clinical trials. Accounts on the offering of payments to participants in clinical trials; Factors influencing the decision of GP to participate in surveys; Impact of the payments on the occurrence of response bias.

  • Teaching appropriate interactions with pharmaceutical company representatives: The impact of an innovative workshop on student attitudes. Wofford, James L.; Ohl, Christopher A. // BMC Medical Education;2005, Vol. 5, p5 

    Background: Pharmaceutical company representatives (PCRs) influence the prescribing habits and professional behaviour of physicians. However, the skills for interacting with PCRs are not taught in the traditional medical school curriculum. We examined whether an innovative, mandatory workshop...

  • Marketing Pharmaceutical Products to Physicians. Creyer, Elizabeth H.; Hrsistodoulakis, Ilias // Marketing Health Services;Summer98, Vol. 18 Issue 2, p34 

    The article presents the results of a survey exploring the impact of marketing practices on physicians and their attitudes towards the pharmaceutical industry. Doctors' perceptions of the pharmaceutical industry are reviewed, concerning such things as its level of understanding of the quality...

  • Breaking the Routine. McCarthy, Justin // Pharmaceutical Representative;Oct2009, Vol. 39 Issue 10, p22 

    The article discusses how pharmaceutical representatives break the monotonous routine and repetitiveness of marketing the same products to physicians. The author states that breaking the routine requires using time and energy but the return on investment may be worth the effort. He adds that...

  • E-marketing at the Tipping Point. Stern, David L. // Pharmaceutical Executive;Feb2006 Supplement Handbook, p8 

    The article discusses guidelines in e-marketing in the pharmaceutical sector in the United States. Marketers must forge a relationship before they can ask for a sale. Making physicians a partner on patient education aids build a positive relationship, giving marketers an edge when it comes to...

  • Rep Alert. Koroneos, George // Pharmaceutical Executive;Jan2008, Vol. 28 Issue 1, p26 

    The article reports on the findings of a study conducted by SK&A Information Services Inc. regarding the relationship between physicians and pharmaceutical sales representatives. It shows that almost one-fifth of U.S. office-based physicians refuse to see medical representatives at any time of...

  • Dramaturgical study of meetings between general practitioners and representatives of pharmaceutical companies. Somerset, Maggie; Weiss, Marjorie; Fahey, Tom; Mears, Robert // BMJ: British Medical Journal (International Edition);12/22/2001, Vol. 323 Issue 7327, p1481 

    Objectives: To examine the interaction between general practitioners and pharmaceutical company representatives. Design: Qualitative study of 13 consecutive meetings between general practitioner and pharmaceutical representatives. A dramaturgical model was used to inform analysis of the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics